Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
"The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension." Allergan Ongoing Bimatoprost SR 3 192024-092 KKESH
The Effectiveness of Convalescent Plasma Transfusion in Preventing Clinical Deterioration and Critical Care Admission in COVID 19 Patients at a Primary Corona Centre in Riyadh, Saudi Arabia PMBAH Ongoing Convalescent Plasma 2 20-252C Prince Mohammad bin Abdulaziz hospital (Riyadh)
The Effectiveness of Convalescent Plasma for the Treatment of Severe COVID-19 Cases in Intensive Care Unit King Faisal Specialist Hospital and Research Centre Ongoing Convalescent Plasma 3 IRB 2020-19-V2 KFSH&RC-J
The effect of Zamzam water on the immunity of healthy university students in the eastern province of Saudi Arabia PI initiated Completed Zamzam water 2 IRB-2020-01-393 Imam Abdulrahman Al Faisal Hospital (Riyadh)
The Effect of Rectal Progesterone on the Latency period as well as Maternal and Prenatal Outcome in PPROM Between 24-33+6 Weeks Umm Al Qura University Ongoing Progesterone 3 ISRCTN65694106 UQU
The effect of cinnamon supplementation on ovulation induction in women with polycystic ovary syndrome, Jeddah 2018: Randomized Double-Blind Placebo-controlled trial Dr. Wael Alzhrani (PI-initiated) Ongoing Cinnamon 3 100-18 KAUH-J
The effect of (Oligonol) and (Oligonol + metformin) on the components of Metabolic Syndrome in obese individuals- A randomized, double-blind, factorial clinical trial. Amino Up Chemical Co., Ltd. Terminated Oligonol 3 SDRG- Amino Up 1 KFMRC-J
Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled Sanofi Completed Lantus® 3 LANTU_C_02762 KFUH
"Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4700 for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Healthy" Inovio Pharmaceuticals, Inc. Completed NO-4700 + CELLECTRA™ 2000 (device) 2 MERS-201 KSMC
Study of Aflibercept in Uveitic Macular EDema (SAUD study) King Khalid Specialist Hospital Rejected Aflibercept 3b 18176 KKESH
View 151 - 160 From 723